Living with strabismus, often referred to as crossed eyes or eye misalignment, can be a physically and emotionally challenging experience. For many, it affects more than just vision; it can impact self-esteem, social interactions, and the ability to make eye contact with confidence. Beyond the cosmetic concerns, the condition can lead to functional issues like double vision, depth perception difficulties, or eye strain that complicates daily tasks such as reading or driving.

Treatment is critical not only to align the eyes but to preserve visual potential. In children, correcting misalignment is urgent to prevent the brain from ignoring one eye, a condition known as amblyopia (lazy eye). In adults, treatment often focuses on eliminating double vision and restoring binocular function. Because strabismus has various causes ranging from muscle weakness to nerve palsies, treatment plans are highly individualized. While corrective lenses and surgery are common interventions, pharmacological options play a significant role for specific types of the condition (American Academy of Ophthalmology, 2023).

Overview of treatment options for Strabismus

The primary goal of treating strabismus is to align the eyes so they look in the same direction at the same time. This alignment allows the brain to fuse the images from both eyes into a single 3D picture. Treatment strategies depend heavily on whether the turn is inward (esotropia) or outward (exotropia), and whether it is intermittent or constant.

While strabismus surgery involves loosening or tightening eye muscles to mechanically correct the alignment, medication-based treatments offer a less invasive alternative for certain patients. These are often used when the deviation is small, sudden in onset, or variable. Medications typically target the muscles or the focusing mechanism of the eye to alter alignment without making permanent surgical changes.

Medications used for Strabismus

The most prominent medication used for treating strabismus is botulinum toxin type A. Commonly known for its cosmetic uses, this neurotoxin is a powerful therapeutic tool for eye misalignment. It is administered via injection directly into the overactive eye muscle. Clinical experience suggests that for certain small-angle deviations or cases where the eye turns inward due to nerve paralysis, this treatment can be as effective as surgery in restoring alignment.

Another class of medications involves miotics, specifically long-acting anticholinesterase agents like echothiophate iodide. These are prescribed as eye drops. They are primarily used for a specific condition called accommodative esotropia, where the eyes cross due to an excessive focusing effort. While less common today than in the past, they remain a valuable tool for patients who cannot tolerate glasses or where glasses alone do not fully straighten the eyes.

For some adults with fluctuating double vision, doctors may treat the underlying condition causing the strabismus, such as Myasthenia Gravis, with drugs like pyridostigmine, though this treats the systemic disease rather than the eye muscles directly (American Association for Pediatric Ophthalmology and Strabismus, 2023).

How these medications work

Botulinum toxin is a neuromuscular blocker. Injected into a stronger eye muscle (e.g., one pulling the eye inward), it causes temporary paralysis. This weakens the muscle, allowing the opposing muscle to realign the eye centrally, creating a new muscle balance.

Miotics affect the eye’s focusing (accommodation) and converging systems. They are used when the eye’s natural inward turning reflex during near focusing is overactive. Miotics stimulate the ciliary muscle to focus without triggering the reflex to cross the eyes, reducing the inward turn while maintaining clear vision (Mayo Clinic, 2022).

Side effects and safety considerations

Strabismus treatments are generally safe, but side effects occur. Botulinum toxin injections often cause temporary upper eyelid drooping (ptosis) if the medication spreads, or temporary double vision as the eyes adjust. These effects typically disappear as the drug wears off.

Miotic eye drops may cause dim vision, brow aches, or headaches, especially initially. Rarely, long-term use can cause iris cysts. Since these drugs affect the nervous system or vision, careful dosing and monitoring are essential. Patients should seek medical attention for severe eye pain, persistent vision loss, or allergic reactions.

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. American Academy of Ophthalmology. https://www.aao.org
  2. American Association for Pediatric Ophthalmology and Strabismus. https://www.aapos.org
  3. Mayo Clinic. https://www.mayoclinic.org
  4. National Eye Institute. https://www.nei.nih.gov

Medications for Strabismus

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Strabismus.

Found 1 Approved Drug for Strabismus

Phospholine

Generic Name
Echothiophate

Phospholine

Generic Name
Echothiophate
Reduction of Elevated IOP Echothiophate iodide for ophthalmic solution is indicated for the reduction of elevated IOP. Accommodative Esotropia Concomitant esotropias with a significant accommodative component.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances